Subcutaneous ICD Reduces Lead-Related Complications

MONDAY, Nov. 7, 2022 (HealthDay News) -- The subcutaneous implantable cardioverter defibrillator (S-ICD) reduces lead-related complications, according to a study published online Nov. 8 in the Annals of Internal Medicine.
Jeff S. Healey, M.D., from the Population Health Research Institute in Hamilton, Ontario, Canada, and colleagues assessed key ICD performance measures related to delivery of ICD therapy, including inappropriate ICD shocks and failed ICD shocks, in a multicenter trial involving 544 eligible patients with a primary or secondary indication for an ICD aged younger than 60 years and with cardiogenetic phenotype or prespecified risk factors for lead complications. Overall, 503 patients were randomly assigned to S-ICD or transvenous ICD (TV-ICD; 251 and 252 patients, respectively) and were followed for a mean of 2.5 years.
The researchers identified a statistically significant reduction in perioperative, lead-related complications, which occurred in 0.4 and 4.8 percent of patients with an S-ICD and TV-ICD, respectively. A trend for more inappropriate shocks was seen with S-ICD (hazard ratio, 2.37; 95 percent confidence interval, 0.98 to 5.77), but there was no increase in failed appropriate ICD shocks (hazard ratio, 0.61; 95 percent confidence interval, 0.15 to 2.57). More ICD site pain was reported by patients in the S-ICD group on the day of implant and one month later.
"The S-ICD is an alternative to a TV-ICD, particularly in patients at increased risk for lead-related complications," the authors write.
The study was funded by Boston Scientific.
Abstract/Full Text (subscription or payment may be required)
Related Posts
Health Highlights: March 15, 2022
Poll finds Americans unclear about age-linked memory loss. Mild cognitive...
Las personas infectadas obtienen una inmunidad duradera contra el coronavirus, según un estudio
MIÉRCOLES, 2 de marzo de 2022 (HealthDay News) -- Las personas que han tenido...
Cemiplimab + Chemotherapy Aids Quality of Life With Lung Cancer
WEDNESDAY, May 10, 2023 (HealthDay News) -- Cemiplimab plus chemotherapy results...
Fully Immunized Colin Powell Dies of COVID: Can Vaccines Protect You?
MONDAY, Oct. 18, 2021 (HealthDay News) -- Colin Powell, the country's first...
